An induction in hepatic HDL secretion associated with reduced ATPase expression

American Journal of Pathology

Volumn 175, Issue 4, 2009, Pages 1777-1787

  Pandey, Nihar R ^a   Renwick, Joanna ^a   Rabaa, Seham ^a   Misquith, Ayesha ^a   Kouri, Lara ^a   Twomey, Erin ^a   Sparks, Daniel L ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; PRE BETA HIGH DENSITY LIPOPROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIPOPROTEIN SECRETION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 73549124583     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090082     Document Type: Article

References (61)

1. Barter P, Kastelein J, Nunn A, Hobbs R: High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions. Atherosclerosis 2003, 168:195-211
2. Brewer HB Jr, Santamarina-Fojo S: New insights into the role of the adenosine triphosphate-binding cassette transporters in high-density lipoprotein metabolism and reverse cholesterol transport. Am J Cardiol 2003, 91:3E-11E
3. Rader DJ: Molecular regulation of HDL metabolism and function: implications for novel therapies. J Clin Invest 2006, 116:3090-3100
4. Fielding CJ, Fielding PE: Cellular cholesterol efflux. Biochim Biophys Acta 2001, 1533:175-189
5. Oram JF: HDL Apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol. Arterioscler Thromb Vasc Biol 2003, 23:720-727
6. Oram JF, Vaughan AM: ATP-Binding cassette cholesterol transporters and cardiovascular disease. Circ Res 2006, 99:1031-1043
7. Venkateswaran A, Laffitte BA, Joseph SB, Mak PA, Wilpitz DC, Edwards PA, Tontonoz P: Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci USA 2000, 97:12097-12102
8. Huuskonen J, Vishnu M, Chau P, Fielding PE, Fielding CJ: Liver X receptor inhibits the synthesis and secretion of apolipoprotein A1 by human liver-derived cells. Biochemistry 2006, 45:15068-15074
9. Wang N, Silver DL, Costet P, Tall AR: Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem 2000, 275:33053-33058
10. Nieland TJ, Chroni A, Fitzgerald ML, Maliga Z, Zannis VI, Kirchhausen T, Krieger M: Cross-inhibition of SR-BI- and ABCA1-mediated cholesterol transport by the small molecules BLT-4 and glyburide. J Lipid Res 2004, 45:1256-1265
11. Hassan HH, Denis M, Lee DY, Iatan I, Nyholt D, Ruel I, Krimbou L, Genest J: Identification of an ABCA1-dependent phospholipid-rich plasma membrane apolipoprotein A-I binding site for nascent HDL formation: implications for current models of HDL biogenesis. J Lipid Res 2007, 48:2428-2442
12. Denis M, Landry YD, Zha X: ATP-binding cassette A1-mediated lipidation of apolipoprotein A-I occurs at the plasma membrane and not in the endocytic compartments. J Biol Chem 2008, 283:16178-16186
13. Faulkner LE, Panagotopulos SE, Johnson JD, Woollett LA, Hui DY, Witting SR, Maiorano JN, Davidson WS: An analysis of the role of a retroendocytosis pathway in ABCA1-mediated cholesterol efflux from macrophages. J Lipid Res 2008, 49:1322-1332
14. Hassan HH, Bailey D, Lee DY, Iatan I, Hafiane A, Ruel I, Krimbou L, Genest J: Quantitative analysis of ABCA1-dependent compartmentalization and trafficking of apolipoprotein A-I: implications for determining cellular kinetics of nascent high density lipoprotein biogenesis. J Biol Chem 2008, 283:11164-11175
15. Singh T, Singh S, Bhullar GS: The effect of sulphonylurea therapy on serum total cholesterol and high density lipoprotein cholesterol. J Indian Med Assoc 1992, 90:259-261
16. Kerenyi Z, Samer H, James R, Yan Y, Stewart M: Combination therapy with rosiglitazone and glibenclamide compared with upward titration of glibenclamide alone in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2004, 63:213-223
17. Takahashi K, Kimura Y, Kioka N, Matsuo M, Ueda K: Purification and ATPase activity of human ABCA1. J Biol Chem 2006, 281: 10760-10768
18. Nofer JR, Remaley AT, Feuerborn R, Wolinnska I, Engel T, von EA, Assmann G: Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter. J. Lipid Res. 2006, 47:794-803
19. Smud R, Sermukslis B: Bezafibrate and fenofibrate in type II diabetics with hyperlipoproteinaemia. Curr Med Res Opin 1987, 10:612-624
20. Martinez LO, Jacquet S, Esteve JP, Rolland C, Cabezon E, Champagne E, Pineau T, Georgeaud V, Walker JE, Terce F, Collet X, Perret B, Barbaras R: Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis. Nature 2003, 421:75-79
21. Martinez LO, Jacquet S, Terce F, Collet X, Perret B, Barbaras R: New insight on the molecular mechanisms of high-density lipoprotein cellular interactions. Cell Mol Life Sci 2004, 61:2343-2360
22. Jacquet S, Malaval C, Martinez LO, Sak K, Rolland C, Perez C, Nauze M, Champagne E, Terce F, Gachet C, Perret B, Collet X, Boeynaems JM, Barbaras R: The nucleotide receptor P2Y13 is a key regulator of hepatic high-density lipoprotein (HDL) endocytosis. Cell Mol Life Sci 2005, 62:2508-2515
23. Fabre AC, Vantourout P, Champagne E, Terce F, Rolland C, Perret B, Collet X, Barbaras R, Martinez LO: Cell surface adenylate kinase activity regulates the F(1)-ATPase/P2Y (13)-mediated HDL endocytosis pathway on human hepatocytes. Cell Mol Life Sci 2006, 63:2829-2837
24. Zhang LH, Kamanna VS, Zhang MC, Kashyap ML: Niacin inhibits surface expression of ATP synthase {beta} chain in HepG2 cells: implications for raising HDL. J Lipid Res 2008, 49:1195-1201
25. Pandey NR, Renwick J, Misquith A, Sokoll K, Sparks DL: Linoleic acid-enriched phospholipids act through peroxisome proliferator-activated receptors alpha to stimulate hepatic apolipoprotein A-I secretion. Biochemistry 2008, 47:1579-1587
26. Hopewell S, Pandey NR, Misquith A, Twomey E, Sparks DL: Phosphatidylinositol acts through mitogen-activated protein kinase to stimulate hepatic apolipoprotein A-I secretion. Metabolism 2008, 57:1677-1684
27. Pandey NR, Sparks DL: Phospholipids as cardiovascular therapeutics. Curr Opin Investig Drugs 2008, 9:281-285
28. Kauffmann HM, Keppler D, Kartenbeck J, Schrenk D: Induction of cMrp/cMoat gene expression by cisplatin, 2-acetylaminofluorene, or cycloheximide in rat hepatocytes. Hepatology 1997, 26:980-985
29. Draber P, Draberova L, Heneberg P, Smid F, Farghali H, Draber P: Preformed STAT3 transducer complexes in human HepG2 cells and rat hepatocytes. Cell Signal 2007, 19:2400-2412
30. Sparks DL, Phillips MC: Quantitative measurement of lipoprotein surface charge by agarose gel electrophoresis. J Lipid Res 1992, 33:123-130
31. Chau P, Nakamura Y, Fielding CJ, Fielding PE: Mechanism of prebeta-HDL formation and activation. Biochemistry 2006, 45: 3981-3987
32. Wang Y, Oram JF: Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1. J Biol Chem 2002, 277:5692-5697
33. Uehara Y, Miura S, von von Eckardstein A, Abe S, Fujii A, Matsuo Y, Rust S, Lorkowski S, Assmann G, Yamada T, Saku K: Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. Atherosclerosis 2007, 191:11-21
34. Sevov M, Elfineh L, Cavelier LB: Resveratrol regulates the expression of LXR-alpha in human macrophages. Biochem Biophys Res Commun 2006, 348:1047-1054
35. Arakawa R, Yokoyama S: Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation. J Biol Chem 2002, 277:22426-22429
36. Vu-Dac N, Schoonjans K, Laine B, Fruchart JC, Auwerx J, Staels B: Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. J Biol Chem 1994, 269:31012-31018
37. Kockx M, Princen HMG, Kooistra T: Studies on the role of PPAR in the fibrate-modulated gene expression of apolipoprotein A-I, plasminogen activator inhibitor 1, and fibrinogen in primary hepatocyte cultures from cynomolgus monkey. Ann NY Acad Sci 1996, 804:711-712
38. Han CY, Chiba T, Campbell JS, Fausto N, Chaisson M, Orasanu G, Plutzky J, Chait A: Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes. Arterioscler Thromb Vasc Biol 2006, 26:1806-1813
39. Barter PJ, Rye KA: Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome? Arterioscler Thromb Vasc Biol 2008, 28:39-46
40. Jin FY, Kamanna VS, Kashyap ML: Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport. Arterioscler Thromb Vasc Biol 1997, 17:2020-2028
41. Malik S, Kashyap ML: Niacin, lipids, and heart disease. Curr Cardiol Rep 2003, 5:470-476
42. Williams KJ, Brocia RW, Fisher EA: The unstirred water layer as a site of control of apolipoprotein B secretion. J Biol Chem 1990, 265:16741-16744
43. Hersberger M, von Eckardstein A: Modulation of high-density lipoprotein cholesterol metabolism and reverse cholesterol transport. Handb Exp Pharmacol 2005, 170:537-561
44. Krieger M: Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. J Clin Invest 2001, 108:793-797
45. Silver DL, Wang N, Xiao X, Tall AR: High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion. J Biol Chem 2001, 276:25287-25293
46. Cavelier C, Rohrer L, von Eckardstein A: ATP-Binding cassette transporter A1 modulates apolipoprotein A-I transcytosis through aortic endothelial cells. Circ Res 2006, 99:1060-1066
47. Pagler TA, Rhode S, Neuhofer A, Laggner H, Strobl W, Hinterndorfer C, Volf I, Pavelka M, Eckhardt ER, van der Westhuyzen DR, Schutz GJ, Stangl H: SR-BI-mediated high density lipoprotein (HDL) endocytosis leads to HDL resecretion facilitating cholesterol efflux. J Biol Chem 2006, 281:11193-11204
48. Wang N, Silver DL, Thiele C, Tall AR: ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J Biol Chem 2001, 276:23742-23747
49. Cavelier C, Lorenzi I, Rohrer L, von Eckardstein A: Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1. Biochim Biophys Acta 2006, 1761:655-666
50. Singaraja RR, Brunham LR, Visscher H, Kastelein JJ, Hayden MR: Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol 2003, 23:1322-1332
51. Maric J, Kiss RS, Franklin V, Marcel YL: Intracellular lipidation of newly synthesized apolipoprotein A-I in primary murine hepatocytes. J Biol Chem 2005, 280:39942-39949
52. Timmins JM, Lee JY, Boudyguina E, Kluckman KD, Brunham LR, Mulya A, Gebre AK, Coutinho JM, Colvin PL, Smith TL, Hayden MR, Maeda N, Parks JS: Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J Clin Invest 2005, 115:1333-1342
53. Guan JZ, Tamasawa N, Murakami H, Matsui J, Yamato K, Suda T: Clofibrate, a peroxisome-proliferator, enhances reverse cholesterol transport through cytochrome P450 activation and oxysterol generation. Tohoku J Exp Med 2003, 201:251-259
54. Knight BL, Patel DD, Humphreys SM, Wiggins D, Gibbons GF: Inhibition of cholesterol absorption associated with a PPAR alpha-dependent increase in ABC binding cassette transporter A1 in mice. J Lipid Res 2003, 44:2049-2058
55. Uehara Y, Engel T, Li Z, Goepfert C, Rust S, Zhou X, Langer C, Schachtrup C, Wiekowski J, Lorkowski S, Assmann G, von Eckardstein A: Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1. Diabetes 2002, 51:2922-2928
56. Wang Y, Oram JF: Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway. J Biol Chem 2005, 280:35896-35903
57. Gledhill JR, Walker JE: Inhibition sites in F1-ATPase from bovine heart mitochondria. Biochem J 2005, 386:591-598
58. Burth P, Younes-Ibrahim M, Santos MC, Castro-Faria Neto HC, de Castro Faria MV: Role of nonesterified unsaturated fatty acids in the pathophysiological processes of leptospiral infection. J Infect Dis 2005, 191:51-57
59. Champagne E, Martinez LO, Collet X, Barbaras R: Ecto-F1Fo ATP synthase/F1 ATPase: metabolic and immunological functions. Curr Opin Lipidol 2006, 17:279-284
60. McLeod LE, Proud CG: ATP depletion increases phosphorylation of elongation factor eEF2 in adult cardiomyocytes independently of inhibition of mTOR signalling. FEBS Lett 2002, 531:448-452
61. Stefanelli C, Bonavita F, Stanic I, Farruggia G, Falcieri E, Robuffo I, Pignatti C, Muscari C, Rossoni C, Guarnieri C, Caldarera CM: ATP depletion inhibits glucocorticoid-induced thymocyte apoptosis. Biochem J 1997, 322 (Pt 3):909-917